Skip to main content
Fig. 2 | BMC Bioinformatics

Fig. 2

From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals

Fig. 2

First scenario: primovaccination in adults. comparison between antibody curve ( ) generated by the model for 5000 days of simulation and experimental data ( ) obtained from primo-vaccinated individuals in the same period. The zoom in the figure shows in more details experimental and numerical results for the first 100 days after vaccination

Back to article page